Magnetic Beads for Desalting of Monoclonal Antibodies and Antibody-Drug Conjugates.

This study focuses on magnetic beads for desalting of monoclonal antibodies and antibody-drug conjugates.. The research employs high-performance liquid chromatography (HPLC) techniques to address analytical challenges in the biopharmaceutical field. Characterization of antibody-drug conjugates (ADCs) using mass spectrometry (MS) is important in drug discovery and formulation development and as part of the quality control processes. To facilitate electrospray ionization (ESI) and produce high-quality mass spectra, common components of storage solutions for monoclonal antibodies (mAbs) and ADCs, such as nonvolatile phosphate-buffered... Research Background and Significance The biopharmaceutical industry heavily relies on monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) as therapeutic agents for a variety of diseases, including cancers and autoimmune disorders. These complex biomolecules require rigorous analytical characterization to ensure safety, efficacy, and quality during drug development and manufacturing. One critical analytical challenge is the removal of interfering nonvolatile buffer components commonly found in mAb and ADC storage solutions, such as phosphate-buffered saline. These components can severely impair downstream mass spectrometry (MS) analyses, especially electrospray ionization (ESI) techniques, by suppressing ionization and contaminating the ion source. Magnetic bead-based desalting methods offer a promising alternative to traditional dialysis or spin filters, providing rapid, efficient sample cleanup that is compatible with high-throughput workflows. This study by Källsten et al. explores the integration of magnetic bead desalting with high-performance liquid chromatography (HPLC) and MS for improved analytical characterization of